Back to Results
First PageMeta Content
HealthCap / Versant / Chemotherapy


VERSANT VENTURES BACKS APREA AB CONTINUING GLOBAL INVESTMENT STRATEGY -- Tenth company sourced by firm’s European team in the past five years -- -- Developing first ever therapy targeting the tumor suppressing protein
Add to Reading List

Document Date: 2016-03-09 17:09:48


Open Document

File Size: 46,51 KB

Share Result on Facebook
UPDATE